Отправить статью по E-mail Development of a Dosage Form of the New Antitumor Antibiotic Olivamide
- Авторы: Tevyashova A.N.1,2, Bychkova E.N.1, Dezhenkova L.G.1, Shchekotikhin A.E.1,2
-
Учреждения:
- G. F. Gause Institute of New Antibiotics (GINA)
- D. Mendeleev University of Chemical Technology of Russia
- Выпуск: Том 52, № 11 (2019)
- Страницы: 930-935
- Раздел: Drug Synthesis Methods and Manufacturing Technology
- URL: https://ogarev-online.ru/0091-150X/article/view/245540
- DOI: https://doi.org/10.1007/s11094-019-01928-x
- ID: 245540
Цитировать
Открытый доступ
Доступ предоставлен
Только для подписчиков
Аннотация
Methods for selective chemical modification of the antitumor antibiotic olivomycin A(OA) were developed at GINA. The compound olivamide with advantages over starting OA was selected from series of OA analogs. The goal of the present work was to develop a dosage form of the antitumor semi-synthetic antibiotic olivamide that guaranteed the stability and high specific activity of olivamide drug substance and was designed for further comprehensive preclinical studies.
Ключевые слова
Об авторах
A. Tevyashova
G. F. Gause Institute of New Antibiotics (GINA); D. Mendeleev University of Chemical Technology of Russia
Автор, ответственный за переписку.
Email: chulis@mail.ru
Россия, 11/1 Bol’shaya Pirogovskaya St., Moscow, 119021; 9 Miusskaya Sq., Moscow, 125047
E. Bychkova
G. F. Gause Institute of New Antibiotics (GINA)
Email: chulis@mail.ru
Россия, 11/1 Bol’shaya Pirogovskaya St., Moscow, 119021
L. Dezhenkova
G. F. Gause Institute of New Antibiotics (GINA)
Email: chulis@mail.ru
Россия, 11/1 Bol’shaya Pirogovskaya St., Moscow, 119021
A. Shchekotikhin
G. F. Gause Institute of New Antibiotics (GINA); D. Mendeleev University of Chemical Technology of Russia
Email: chulis@mail.ru
Россия, 11/1 Bol’shaya Pirogovskaya St., Moscow, 119021; 9 Miusskaya Sq., Moscow, 125047
Дополнительные файлы
